43 related articles for article (PubMed ID: 11435430)
1. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1.
Basak A; Koch P; Dupelle M; Fricker LD; Devi LA; Chrétien M; Seidah NG
J Biol Chem; 2001 Aug; 276(35):32720-8. PubMed ID: 11435430
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.
Fricker LD; McKinzie AA; Sun J; Curran E; Qian Y; Yan L; Patterson SD; Courchesne PL; Richards B; Levin N; Mzhavia N; Devi LA; Douglass J
J Neurosci; 2000 Jan; 20(2):639-48. PubMed ID: 10632593
[TBL] [Abstract][Full Text] [Related]
3.
Mack SM; Gomes I; Fakira AK; Duarte ML; Gupta A; Fricker L; Devi LA
Mol Pharmacol; 2022 May; 102(1):29-38. PubMed ID: 35605991
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of a novel variant of PCSK1.
Pickett LA; Yourshaw M; Albornoz V; Chen Z; Solorzano-Vargas RS; Nelson SF; Martín MG; Lindberg I
PLoS One; 2013; 8(1):e55065. PubMed ID: 23383060
[TBL] [Abstract][Full Text] [Related]
5. Publisher Correction: Increased expression and retention of the secretory chaperone proSAAS following cell stress.
Shakya M; Yildirim T; Lindberg I
Cell Stress Chaperones; 2020 Nov; 25(6):943. PubMed ID: 32691307
[TBL] [Abstract][Full Text] [Related]
6. Proteomics in Patients with Fibromyalgia Syndrome: A Systematic Review of Observational Studies.
Gkouvi A; Tsiogkas SG; Bogdanos DP; Gika H; Goulis DG; Grammatikopoulou MG
Curr Pain Headache Rep; 2024 Apr; ():. PubMed ID: 38652420
[TBL] [Abstract][Full Text] [Related]
7. Mice lacking proSAAS display alterations in emotion, consummatory behavior and circadian entrainment.
Aryal DK; Rodriguiz RM; Nguyen NL; Pease MW; Morgan DJ; Pintar J; Fricker LD; Wetsel WC
Genes Brain Behav; 2022 Sep; 21(7):e12827. PubMed ID: 35878875
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and Regulation.
Mack SM; Gomes I; Devi LA
ACS Chem Neurosci; 2019 Apr; 10(4):1884-1891. PubMed ID: 30726666
[TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase E and the Identification of Novel Neuropeptides as Potential Therapeutic Targets.
Fricker LD
Adv Pharmacol; 2018; 82():85-102. PubMed ID: 29413529
[TBL] [Abstract][Full Text] [Related]
10. ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine.
Berezniuk I; Rodriguiz RM; Zee ML; Marcus DJ; Pintar J; Morgan DJ; Wetsel WC; Fricker LD
J Neurochem; 2017 Nov; 143(3):268-281. PubMed ID: 28881029
[TBL] [Abstract][Full Text] [Related]
11. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity.
Philippe J; Stijnen P; Meyre D; De Graeve F; Thuillier D; Delplanque J; Gyapay G; Sand O; Creemers JW; Froguel P; Bonnefond A
Int J Obes (Lond); 2015 Feb; 39(2):295-302. PubMed ID: 24890885
[TBL] [Abstract][Full Text] [Related]
12. Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.
Peinado JR; Sami F; Rajpurohit N; Lindberg I
FEBS Lett; 2013 Nov; 587(21):3406-11. PubMed ID: 24042052
[TBL] [Abstract][Full Text] [Related]
13. Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.
Gagnon H; Refaie S; Gagnon S; Desjardins R; Salzet M; Day R
PLoS One; 2013; 8(4):e61557. PubMed ID: 23637853
[TBL] [Abstract][Full Text] [Related]
14. The extended granin family: structure, function, and biomedical implications.
Bartolomucci A; Possenti R; Mahata SK; Fischer-Colbrie R; Loh YP; Salton SR
Endocr Rev; 2011 Dec; 32(6):755-97. PubMed ID: 21862681
[TBL] [Abstract][Full Text] [Related]
15. Modulation of PC1/3 activity by self-interaction and substrate binding.
Hoshino A; Kowalska D; Jean F; Lazure C; Lindberg I
Endocrinology; 2011 Apr; 152(4):1402-11. PubMed ID: 21303942
[TBL] [Abstract][Full Text] [Related]
16. Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.
Funkelstein L; Beinfeld M; Minokadeh A; Zadina J; Hook V
Neuropeptides; 2010 Dec; 44(6):457-66. PubMed ID: 21047684
[TBL] [Abstract][Full Text] [Related]
17. Congenital ureteropelvic junction obstruction: human disease and animal models.
Klein J; Gonzalez J; Miravete M; Caubet C; Chaaya R; Decramer S; Bandin F; Bascands JL; Buffin-Meyer B; Schanstra JP
Int J Exp Pathol; 2011 Jun; 92(3):168-92. PubMed ID: 20681980
[TBL] [Abstract][Full Text] [Related]
18. Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.
Ozawa A; Peinado JR; Lindberg I
Endocrinology; 2010 Sep; 151(9):4437-45. PubMed ID: 20610561
[TBL] [Abstract][Full Text] [Related]
19. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics.
Wardman JH; Zhang X; Gagnon S; Castro LM; Zhu X; Steiner DF; Day R; Fricker LD
J Neurochem; 2010 Jul; 114(1):215-25. PubMed ID: 20412386
[TBL] [Abstract][Full Text] [Related]
20. The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.
Morgan DJ; Wei S; Gomes I; Czyzyk T; Mzhavia N; Pan H; Devi LA; Fricker LD; Pintar JE
J Neurochem; 2010 Jun; 113(5):1275-84. PubMed ID: 20367757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]